Cabozantinib as the first step toward postimmunotherapy treatment in hepatocellular carcinoma.

Authors :: Pei B
Yang H
Peng S
Zhou F
Source :: Journal of surgical oncology [J Surg Oncol] 2024 Aug; Vol. 130 (2), pp. 343-344. Date of Electronic Publication: 2024 Jun 21.
Publication Year :: 2024

Subjects :: Humans
Antineoplastic Agents therapeutic use
Carcinoma, Hepatocellular drug therapy
Carcinoma, Hepatocellular therapy
Liver Neoplasms drug therapy
Liver Neoplasms therapy
Pyridines therapeutic use
Anilides therapeutic use

Full Text Access

Tools